BridgeBio Pharma Inc.
BBIO | NASDAQ
$75.80
+$0.85 (+1.13%)
Nov 2, 2026, 12:21 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 570.12M | 681.1M | 375.94M | 376.69M | 393.77M | 356.08M |
Short-Term Investments | 17.36M | n/a | 58.95M | 95.23M | 442.89M | 251.01M |
Long-Term Investments | 81.44M | 143.75M | 3.74M | 2.87M | 2.42M | n/a |
Other Long-Term Assets | -81.44M | 18.2M | 18.88M | 17.36M | 30.61M | 23.93M |
Receivables | 139.44M | 4.72M | 1.75M | 17.08M | 19.75M | n/a |
Inventory | 26.75M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 3.83M | 27.65M | 37.93M | 177K | 139K |
Total Current Assets | 753.68M | 720.69M | 477.59M | 548.85M | 888.86M | 642.82M |
Property-Plant & Equipment | 13.52M | 12.78M | 19.84M | 25.25M | 45.97M | 36.83M |
Goodwill & Intangibles | 28.08M | 23.93M | 26.32M | 28.71M | 44.93M | n/a |
Total Long-Term Assets | 41.59M | 198.65M | 68.79M | 74.18M | 123.93M | 60.76M |
Total Assets | 936.03M | 919.34M | 546.38M | 623.04M | 1.01B | 703.59M |
Account Payables | 36.23M | 9.62M | 10.66M | 11.56M | 11.88M | 8.95M |
Deferred Revenue | 20.27M | n/a | 6.1M | 8.16M | n/a | n/a |
Short-Term Debt | 17.41M | n/a | n/a | n/a | n/a | 1.46M |
Other Current Liabilities | 214.06M | 16.2M | 65.6M | 31.26M | 37.04M | 9.55M |
Total Current Liabilities | 287.97M | 154.4M | 143.84M | 121.43M | 135.07M | 95.65M |
Long-Term Debt | 2.71B | 1.72B | 1.73B | 1.71B | 1.7B | 475.86M |
Other Long-Term Liabilities | 244K | 496.47M | 9.36M | 26.64M | 22.07M | 9.52M |
Total Long-Term Liabilities | 2.72B | 2.22B | 1.75B | 1.75B | 1.74B | 500.05M |
Total Liabilities | 3.01B | 2.38B | 1.89B | 1.87B | 1.88B | 595.7M |
Total Debt | 2.73B | 1.73B | 1.74B | 1.72B | 1.73B | 495.79M |
Book Value | -2.08B | -1.46B | -1.34B | -1.24B | -865.58M | 107.89M |
Book Value Per Share | -10.53 | -7.83 | -8.25 | -8.44 | -6 | 0.91 |
Common Stock | 202K | 196K | 181K | 157K | 154K | 125K |
Retained Earnings | -3.82B | -3.1B | -2.56B | -1.92B | -1.44B | -888.76M |
Comprehensive Income | 12K | 8K | 31K | -328K | -132K | 192K |
Shareholders Equity | -2.08B | -1.47B | -1.35B | -1.25B | -870.41M | 57.91M |
Total Investments | 98.81M | 143.75M | 62.69M | 98.1M | 445.31M | 251.01M |
Add to Watchlist
Select watchlists to add or remove BBIO